Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett Syndrome
Clinical trial NCT07480564 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07480564
- Sponsor
- Taysha Gene Therapies, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-08
- Primary completion
- 2031-06-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.